Source: Pulmonary Pharmacology & Therapeutics. Unidade: FMRP
Subjects: DOENÇA PULMONAR OBSTRUTIVA CRÔNICA, CÉLULAS ESTROMAIS, ENFISEMA PULMONAR, CÉLULAS-TRONCO
ABNT
FARIA, Carolina Arruda de et al. Mesenchymal stromal cells-based therapy in a murine model of elastase-induced emphysema: simvastatin as a potential adjuvant in cellular homing. Pulmonary Pharmacology & Therapeutics, v. 70, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.pupt.2021.102075. Acesso em: 25 ago. 2024.APA
Faria, C. A. de, Silva Junior, W. A. da, Coelho, K. B. C. A., Bassi, M., Colombari, E., Zanette, D. L., & Paes, J. T. R. (2021). Mesenchymal stromal cells-based therapy in a murine model of elastase-induced emphysema: simvastatin as a potential adjuvant in cellular homing. Pulmonary Pharmacology & Therapeutics, 70, 1-10. doi:10.1016/j.pupt.2021.102075NLM
Faria CA de, Silva Junior WA da, Coelho KBCA, Bassi M, Colombari E, Zanette DL, Paes JTR. Mesenchymal stromal cells-based therapy in a murine model of elastase-induced emphysema: simvastatin as a potential adjuvant in cellular homing [Internet]. Pulmonary Pharmacology & Therapeutics. 2021 ; 70 1-10.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.pupt.2021.102075Vancouver
Faria CA de, Silva Junior WA da, Coelho KBCA, Bassi M, Colombari E, Zanette DL, Paes JTR. Mesenchymal stromal cells-based therapy in a murine model of elastase-induced emphysema: simvastatin as a potential adjuvant in cellular homing [Internet]. Pulmonary Pharmacology & Therapeutics. 2021 ; 70 1-10.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1016/j.pupt.2021.102075